Home / Research / Product codes / NQD Medical-device intelligence
NQD: Cardiac C-Reactive Protein, Antigen, Antiserum, And Control FDA product code NQD: Cardiac C-Reactive Protein, Antigen, Antiserum, And Control. View classification details, related manufacturers, 510(k) clearances, and recall records.
Classification details
Product code NQD
FDA device name Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Device class 2
Regulation number 866.5270
Medical specialty Immunology
Review panel IM FDA definition In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments. Explore immunology records → A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.
Record activity in this scope 19 clearance records and 3 recall records in the covered releases, across 12 source company names and 1 product codes. Dated history runs from Jan 22, 2004 to Apr 2, 2026.
Monthly counts through October 2026 Month 510(k) decisions Recall initiations October 2025 0 0 November 2025 0 0 December 2025 0 0 January 2026 0 0 February 2026 0 0 March 2026 0 0 April 2026 1 0 May 2026 0 0 June 2026 0 0 July 2026 0 0 August 2026 0 0 September 2026 0 0 October 2026 0 0
Product codes represented All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.
Clearances and recall records 22 matching records Device / record Company in FDA record Source Source date Tina-quant Cardiac high sensitivity CRP III K260026 · NQDRoche Diagnostics 510(k) Apr 2, 2026FDA decision date Atellica® CH High Sensitivity C-Reactive Protein 2 (hCRP2) K233242 · NQDSiemens Healthcare Diagnostics, Inc. 510(k) Jan 18, 2024FDA decision date CardioPhase® hsCRP K212559 · NQDSiemens Healthcare Diagnostics Products GmbH 510(k) Dec 16, 2022FDA decision date CRP Vario K173833 · NQDSENTINEL CH. SpA 510(k) Sep 27, 2018FDA decision date Tina-Quant (Latex) HS Test System
(C-Reactive Protein (Latex) High Sensitive)
The Tina-Quant CRP (Latex) High Sensitive Immunoturbidimetric assay… Z-1092-2017 · NQDRoche Diagnostics Operations, Inc. Recall Jan 24, 2017FDA classification date Siemens Acute Care" CCRP TestPak-in vitro diagnostic product intended to be used for calibration of the CCRP method on the Stratus CS analyzer
Ca… Z-0614-2016 · NQDSiemens Healthcare Diagnostics Inc Recall Jan 7, 2016FDA classification date Siemens Acute Care CCRP CalPak-in vitro diagnostic product intended to be used for calibration of the CCRP method on the Stratus CS analyzer
Cata… Z-0616-2016 · NQDSiemens Healthcare Diagnostics Inc Recall Jan 7, 2016FDA classification date ADVIA CHEMISTRY CARDIOPHASE HIGH SENSITIVITY C-REACTIVE PROTEIN (HSCRP), CALIBRATORS K081294 · NQDSiemens Healthcare Diagnostics, Inc. 510(k) Jul 29, 2008FDA decision date IMMAGE IMMUNOCHEMISTRY SYSTEMS HIGH SENSITIVITY CARDIAC C-REACTIVE PROTEIN (CCRP) REAGENT K071002 · NQDBeckman Coulter, Inc. 510(k) Jun 21, 2007FDA decision date SYNCHRON SYSTEMS HIGH SENSITIVITY CARDIAC C-REACTIVE PROTEIN (CRPH) REAGENT K070626 · NQDBeckman Coulter, Inc. 510(k) May 4, 2007FDA decision date IMMULITE 2500 HIGH SENSITIVITY C-REACTIVE PROTEIN, MODELS L5KCRP (200 TESTS), L5KCRP (600 TESTS) K071017 · NQDSiemens Medical Solutions Diagnostics 510(k) May 2, 2007FDA decision date STRATUS CS ACUTE CARE CARDIOPHASE HSCRP TESTPAK K062924 · NQDDade Behring, Inc. 510(k) Dec 26, 2006FDA decision date IMMULITE/IMMULITE 1000, IMMULITE 2000 HIGH SENSITIVITY CRP K063057 · NQDDiagnostic Products Corporation 510(k) Dec 22, 2006FDA decision date DIMENSION VISTA CARDIOPHASE HSCRP FLEX REAGENT CARTRIDGE, PROTEIN 2 CALIBRATOR, HSCRP CONTROL LOW, HSCRP 1 CONTROL HIGH K061802 · NQDDade Behring, Inc. 510(k) Sep 11, 2006FDA decision date STRATUS CS ACUTE CARE CARDIOPHASE HSCRP TEST PAK, CALPAK, DILPAK K060369 · NQDDade Behring, Inc. 510(k) May 4, 2006FDA decision date C-REACTIVE PROTEIN (LATEX) HIGH SENSITIVE TEST SYSTEM FOR COBAS INTEGRA INSTRUMENTS K053603 · NQDRoche Diagnostics Corp. 510(k) Feb 9, 2006FDA decision date DIMENSION CARDIOPHASE HIGH SENSITIVITY CRP FLEX REAGENT CARTRIDGE K053109 · NQDDade Behring, Inc. 510(k) Dec 23, 2005FDA decision date OLYMPUS CRP LATEX REAGENT, OSR6199; OLYMPUS CRP LATEX CALIBRATOR NORMAL SET, ODC0026; OLYMPUS CRP LATEX CALIBRATOR HIGH K051564 · NQDOlympus America, Inc. 510(k) Aug 22, 2005FDA decision date TINA-QUANT CRP (LATEX) HS TEST SYSTEM (C-REACTIVE PROTEIN (LATEX) HIGH SENSITIVE) K042485 · NQDRoche Diagnostics Corp. 510(k) Oct 29, 2004FDA decision date VITROS CHEMISTRY PRODUCTS HSCRP REAGENT, VITROS CHEMISTRY PRODUCTS CALIBRATOR KIT 17, VITROS CHEMISTRY PRODUCTS FS K041799 · NQDOrtho-Clinical Diagnostics, Inc. 510(k) Aug 25, 2004FDA decision date OLYMPUS CRP LATEX IMMUNOTURBIDIMETRIC REAGENT K041668 · NQDOlympus America, Inc. 510(k) Aug 19, 2004FDA decision date N HIGH SENSITIVITY CRP K033908 · NQDDade Behring, Inc. 510(k) Jan 22, 2004FDA decision date
Manufacturers in these records Device classifications FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
Source classifications may change.
510(k) clearances FDA dataset: Nov 9, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
Recall records FDA dataset: Nov 19, 2026
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Keep this research moving. Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.
Start a 14-day free trial ↗